In contrast, in patients losing response and in non-responders, the expression of both PLCB1 and PLCG1 was almost constant or slightly decreased between T4 and T8, although never reaching the levels of MDS responders nor the healthy subjects (Fig. 3B, C). Here, PLCB1 is linked to myelodysplastic syndrome.